DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2024 were approximately $2.4 million and $7.2 million, respectively, a decrease of approximately $2.2 million and $6.2 million, respectively, when compared to the same periods last year. Net loss for the three and nine months ended July 31, 2024 were approximately $0.3 million and $0.8 million, respectively, compared to the same periods last year to a net income of approximately $0.5 million and $1.4 million, respectively.
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year. Net loss for the three and six months ended April 30, 2024 were approximately $0.2 and $0.5 million, respectively, compared to the same periods last year to a net income of approximately $0.4 and $0.8 million, respectively.
![]() PBSV 29 Jan 2024 | Other | $0.07 Per Share |
![]() PBSV 28 Mar 2023 | Other | $0.07 Per Share |
![]() PBSV 24 Feb 2022 | Other | $0.07 Per Share |
![]() PBSV 14 Dec 2021 | Other | $0.07 Per Share |
![]() PBSV 22 Jan 2021 | Other | $0.07 Per Share |
10 Sep 2025 (In 1 month) Date | | 0.03 Cons. EPS | - EPS |
12 Jun 2025 Date | | 0.03 Cons. EPS | 0 EPS |
17 Mar 2025 Date | | 0.02 Cons. EPS | 0 EPS |
27 Jan 2025 Date | | - Cons. EPS | 0 EPS |
16 Sep 2024 Date | | 0.03 Cons. EPS | - EPS |
![]() PBSV 29 Jan 2024 | Other | $0.07 Per Share |
![]() PBSV 28 Mar 2023 | Other | $0.07 Per Share |
![]() PBSV 24 Feb 2022 | Other | $0.07 Per Share |
![]() PBSV 14 Dec 2021 | Other | $0.07 Per Share |
![]() PBSV 22 Jan 2021 | Other | $0.07 Per Share |
10 Sep 2025 (In 1 month) Date | | 0.03 Cons. EPS | - EPS |
12 Jun 2025 Date | | 0.03 Cons. EPS | 0 EPS |
17 Mar 2025 Date | | 0.02 Cons. EPS | 0 EPS |
27 Jan 2025 Date | | - Cons. EPS | 0 EPS |
16 Sep 2024 Date | | 0.03 Cons. EPS | - EPS |
Health Information Services Industry | Healthcare Sector | Mr. Victor Sanchez CEO | OTCQB Exchange | US71711N1000 ISIN |
US Country | 100 Employees | 15 Feb 2024 Last Dividend | - Last Split | - IPO Date |
Pharma-Bio Serv, Inc. is an established compliance and technology transfer services consulting firm that has been operating since 1993. With a broad geographical footprint, the company offers its specialized services not only in its home base of Puerto Rico but also across the United States, Europe, Brazil, and other international locations. Positioned to serve a diverse range of sectors, including pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, and food industries, Pharma-Bio Serv is dedicated to ensuring its clients meet stringent regulatory standards. Its corporate headquarters are strategically situated in Dorado, Puerto Rico, reinforcing its strong presence within and outside the United States.
This service is critical for companies looking to navigate the complex landscape of regulatory requirements. Pharma-Bio Serv Inc. assists clients in ensuring all aspects of their operation are compliant with the relevant local, national, and international regulatory standards. This is vital for businesses aiming to maintain their licenses to operate, avoid legal issues, and uphold the highest levels of safety and quality in their processes and products.
Validation services are essential for affirming that equipment, systems, and processes perform consistently according to their intended use. Pharma-Bio Serv Inc. offers comprehensive validation services that cover equipment qualification, process validation, and cleaning validation, thereby ensuring that products meet all required standards and specifications for quality and safety.
This service involves the systematic transfer of technology, processes, and methodologies between development and production, or between manufacturing sites. Pharma-Bio Serv Inc. facilitates seamless technology transfer through careful planning, documentation, and execution, ensuring that knowledge is accurately transferred and applied to achieve consistent product quality.
The company provides engineering and project management services to support the design, development, and implementation of projects within the regulated industries. From conceptual design through to final validation, Pharma-Bio Serv Inc. ensures projects are completed on time, within budget, and in compliance with all regulatory requirements. This comprehensive approach helps clients to streamline operations, enhance productivity, and accelerate time to market for their products.
Pharma-Bio Serv Inc. offers process support services that aim to optimize manufacturing processes, improve efficiency, and ensure continuous compliance with industry regulations. This includes troubleshooting process issues, implementing process improvements, and providing ongoing support to maintain operational excellence.